Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Lam

Showing results (291-300 of 436) with videos related to

Pageof 44
Sort By:
Science Translational Medicine|April 9, 2010
Airway PI3K pathway activation is an early and reversible event in lung cancer developmentAdam M Gustafson, Raffaella Soldi, Christina Anderlind, et al.
Hepatology (Baltimore, Md.)|July 5, 2022
Age and the relative importance of liver-related deaths in nonalcoholic fatty liver diseaseHuapeng Lin, Terry Cheuk-Fung Yip, Xinrong Zhang, et al.
Liver Cancer|September 26, 2022
Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres Followed by Gemcitabine plus Cisplatin for Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Single-Arm Multicenter Clinical TrialStephen Lam Chan, Chanisa Chotipanich, Su Pin Choo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 23, 2018
Integrative Genomic Analyses Identifies GGA2 as a Cooperative Driver of EGFR-Mediated Lung TumorigenesisHannah O'Farrell, Bryant Harbourne, Zimple Kurlawala, et al.
Cancer Research|June 28, 2014
A search for novel cancer/testis antigens in lung cancer identifies VCX/Y genes, expanding the repertoire of potential immunotherapeutic targetsAyumu Taguchi, Allen D Taylor, Jaime Rodriguez, et al.
Thorax|January 9, 2024
Radiomics analysis to predict pulmonary nodule malignancy using machine learning approachesMatthew T Warkentin, Hamad Al-Sawaihey, Stephen Lam, et al.
Therapeutic Advances in Medical Oncology|October 7, 2021
ALBI score and outcomes in patients with hepatocellular carcinoma: <i>post hoc</i> analysis of the randomized controlled trial KEYNOTE-240Arndt Vogel, Philippe Merle, Chris Verslype, et al.
Science (New York, N.Y.)|December 16, 2014
Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolatesJudith Straimer, Nina F Gnädig, Benoit Witkowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriersVincent Wai-Sun Wong, Stephen Lam Chan, Frankie Mo, et al.
Hepatology (Baltimore, Md.)|April 29, 2023
Duration of type 2 diabetes and liver-related events in nonalcoholic fatty liver disease: A landmark analysisXinrong Zhang, Terry Cheuk-Fung Yip, Yee-Kit Tse, et al.
Pageof 44

Showing results (291-300 of 436) with videos related to

Sort By:
Pageof 44
Science Translational Medicine|April 9, 2010
Airway PI3K pathway activation is an early and reversible event in lung cancer developmentAdam M Gustafson, Raffaella Soldi, Christina Anderlind, et al.
Hepatology (Baltimore, Md.)|July 5, 2022
Age and the relative importance of liver-related deaths in nonalcoholic fatty liver diseaseHuapeng Lin, Terry Cheuk-Fung Yip, Xinrong Zhang, et al.
Liver Cancer|September 26, 2022
Selective Internal Radiation Therapy with Yttrium-90 Resin Microspheres Followed by Gemcitabine plus Cisplatin for Unresectable Intrahepatic Cholangiocarcinoma: A Phase 2 Single-Arm Multicenter Clinical TrialStephen Lam Chan, Chanisa Chotipanich, Su Pin Choo, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 23, 2018
Integrative Genomic Analyses Identifies GGA2 as a Cooperative Driver of EGFR-Mediated Lung TumorigenesisHannah O'Farrell, Bryant Harbourne, Zimple Kurlawala, et al.
Cancer Research|June 28, 2014
A search for novel cancer/testis antigens in lung cancer identifies VCX/Y genes, expanding the repertoire of potential immunotherapeutic targetsAyumu Taguchi, Allen D Taylor, Jaime Rodriguez, et al.
Thorax|January 9, 2024
Radiomics analysis to predict pulmonary nodule malignancy using machine learning approachesMatthew T Warkentin, Hamad Al-Sawaihey, Stephen Lam, et al.
Therapeutic Advances in Medical Oncology|October 7, 2021
ALBI score and outcomes in patients with hepatocellular carcinoma: <i>post hoc</i> analysis of the randomized controlled trial KEYNOTE-240Arndt Vogel, Philippe Merle, Chris Verslype, et al.
Science (New York, N.Y.)|December 16, 2014
Drug resistance. K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolatesJudith Straimer, Nina F Gnädig, Benoit Witkowski, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 3, 2010
Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriersVincent Wai-Sun Wong, Stephen Lam Chan, Frankie Mo, et al.
Hepatology (Baltimore, Md.)|April 29, 2023
Duration of type 2 diabetes and liver-related events in nonalcoholic fatty liver disease: A landmark analysisXinrong Zhang, Terry Cheuk-Fung Yip, Yee-Kit Tse, et al.
Pageof 44